注册 | 登录 | FAQ      [?] 

Cancer Immunology, Immunotherapy

最近几期的文章@ Cancer Immunology, Immunotherapy © Springer
  • Anti-angiogenic active immunotherapy: a new approach to cancer treatment
    Cancer Immunology, Immunotherapy, Vol. 57, No. 8. (August 2008), pp. 1105-1114.
  • The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients
    Cancer Immunology, Immunotherapy, Vol. 57, No. 8. (August 2008), pp. 1115-1124.
  • Different immune correlates associated with tumor progression and regression: implications for prevention and treatment of cancer
    Cancer Immunology, Immunotherapy, Vol. 57, No. 8. (August 2008), pp. 1125-1136.
  • Activation of extracellular signaling regulated kinase in natural killer cells and monocytes following IL-2 stimulation in vitro and in patients undergoing IL-2 immunotherapy: analysis via dual parameter flow-cytometric assay
    Cancer Immunology, Immunotherapy, Vol. 57, No. 8. (August 2008), pp. 1137-1149.
  • CD40 ligation in vivo can induce T cell independent antitumor effects even against immunogenic tumors
    Cancer Immunology, Immunotherapy, Vol. 57, No. 8. (August 2008), pp. 1151-1160.
  • Delivery of mengovirus-derived RNA replicons into tumoural liver enhances the anti-tumour efficacy of a peripheral peptide-based vaccine
    Cancer Immunology, Immunotherapy, Vol. 57, No. 8. (August 2008), pp. 1161-1171.
  • Use of radiolabeled monoclonal antibody to enhance vaccine-mediated antitumor effects
    Cancer Immunology, Immunotherapy, Vol. 57, No. 8. (August 2008), pp. 1173-1183.
  • Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1
    Cancer Immunology, Immunotherapy, Vol. 57, No. 8. (August 2008), pp. 1185-1195.
  • TGF secreted by B16 melanoma antagonizes cancer gene immunotherapy bystander effect
    Cancer Immunology, Immunotherapy, Vol. 57, No. 8. (August 2008), pp. 1197-1206.
  • Serum antibodies against Saccharomyces cerevisiae: a new prognostic indicator in metastatic renal-cell carcinoma
    Cancer Immunology, Immunotherapy, Vol. 57, No. 8. (August 2008), pp. 1207-1214.
  • Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response
    Cancer Immunology, Immunotherapy, Vol. 57, No. 8. (August 2008), pp. 1215-1223.
  • Preclinical studies in rats and squirrel monkeys for safety evaluation of the bivalent anti-human T cell immunotoxin, A-dmDT390bisFv(UCHT1)
    Cancer Immunology, Immunotherapy, Vol. 57, No. 8. (August 2008), pp. 1225-1239.
  • The anti-tumor agent, ingenol-3-angelate (PEP005), promotes the recruitment of cytotoxic neutrophils by activation of vascular endothelial cells in a PKC- dependent manner
    Cancer Immunology, Immunotherapy, Vol. 57, No. 8. (August 2008), pp. 1241-1251.
  • The neoplastically transformed (CD30hi) Mareks disease lymphoma cell phenotype most closely resembles T-regulatory cells
    Cancer Immunology, Immunotherapy, Vol. 57, No. 8. (August 2008), pp. 1253-1262.
    by Shack, , Buza, , Burgess,
  • Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity
    Cancer Immunology, Immunotherapy, Vol. 57, No. 8. (August 2008), pp. 1263-1270.
  • Local therapy of cancer with free IL-2
    Cancer Immunology, Immunotherapy, Vol. 57, No. 7. (July 2008), pp. 931-950.
  • Tumors skew endothelial cells to disrupt NK cell, T-cell and macrophage functions
    Cancer Immunology, Immunotherapy, Vol. 57, No. 7. (July 2008), pp. 951-961.
  • CD4 and CD8 T cell responses to tumour-associated EpsteinBarr virus antigens in nasopharyngeal carcinoma patients
    Cancer Immunology, Immunotherapy, Vol. 57, No. 7. (July 2008), pp. 963-975.
  • Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responses
    Cancer Immunology, Immunotherapy, Vol. 57, No. 7. (July 2008), pp. 977-986.
  • Immune modulation by melanoma and ovarian tumor cells through expression of the immunosuppressive molecule CD200
    Cancer Immunology, Immunotherapy, Vol. 57, No. 7. (July 2008), pp. 987-996.
    by Siva, , Xin, , Qin, , Oltean, , Bowdish, , Kretz-Rommel,
  • Transient activation of tumor-associated T-effector/memory cells promotes tumor eradication via NK-cell recruitment: minimal role for long-term T-cell immunity in cure of metastatic disease
    Cancer Immunology, Immunotherapy, Vol. 57, No. 7. (July 2008), pp. 997-1005.
  • Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF
    Cancer Immunology, Immunotherapy, Vol. 57, No. 7. (July 2008), pp. 1007-1016.
  • A33 antigen displays persistent surface expression
    Cancer Immunology, Immunotherapy, Vol. 57, No. 7. (July 2008), pp. 1017-1027.
  • Activation of cytotoxic T lymphocytes against CML28-bearing tumors by dendritic cells transduced with a recombinant adeno-associated virus encoding the CML28 gene
    Cancer Immunology, Immunotherapy, Vol. 57, No. 7. (July 2008), pp. 1029-1038.
  • Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma
    Cancer Immunology, Immunotherapy, Vol. 57, No. 7. (July 2008), pp. 1039-1051.
  • Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab)2 fragment of anti-CD16 antibody
    Cancer Immunology, Immunotherapy, Vol. 57, No. 7. (July 2008), pp. 1053-1066.
  • In vivo responses to vaccination with Mage-b, GM-CSF and thioglycollate in a highly metastatic mouse breast tumor model, 4T1
    Cancer Immunology, Immunotherapy, Vol. 57, No. 7. (July 2008), pp. 1067-1077.
  • Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice
    Cancer Immunology, Immunotherapy, Vol. 57, No. 7. (July 2008), pp. 1079-1089.
  • Interactions of host IL-6 and IFN- and cancer-derived TGF-1 on MHC molecule expression during tumor spontaneous regression
    Cancer Immunology, Immunotherapy, Vol. 57, No. 7. (July 2008), pp. 1091-1104.
  • Using extracellular biomarkers for monitoring efficacy of therapeutics in cancer patients: an update
    Cancer Immunology, Immunotherapy, Vol. 57, No. 6. (June 2008), pp. 759-775.
    by Beachy, , Repasky,
  • Tumor-derived death receptor 6 modulates dendritic cell development
    Cancer Immunology, Immunotherapy, Vol. 57, No. 6. (June 2008), pp. 777-787.
  • Langerhans cells and dendritic cells are cytotoxic towards HPV16 E6 and E7 expressing target cells
    Cancer Immunology, Immunotherapy, Vol. 57, No. 6. (June 2008), pp. 789-797.
  • Vaccination with metastasis-related tumor associated antigen TPD52 and CpG/ODN induces protective tumor immunity
    Cancer Immunology, Immunotherapy, Vol. 57, No. 6. (June 2008), pp. 799-811.
  • Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner
    Cancer Immunology, Immunotherapy, Vol. 57, No. 6. (June 2008), pp. 813-821.
  • Mutation in the immunodominant epitope of the HPV16 E7 oncoprotein as a mechanism of tumor escape
    Cancer Immunology, Immunotherapy, Vol. 57, No. 6. (June 2008), pp. 823-831.
  • CD4+ T-cell recognition of human 5T4 oncofoetal antigen: implications for initial depletion of CD25+ T cells
    Cancer Immunology, Immunotherapy, Vol. 57, No. 6. (June 2008), pp. 833-847.
  • Dissection and molecular analysis of alloreactive CD8+ T cell responses in allogeneic haematopoietic stem cell transplantation
    Cancer Immunology, Immunotherapy, Vol. 57, No. 6. (June 2008), pp. 849-857.
  • Allogeneic tumor lysate can serve as both antigen source and protein supplementation for dendritic cell culture
    Cancer Immunology, Immunotherapy, Vol. 57, No. 6. (June 2008), pp. 859-870.
  • Human tankyrases are aberrantly expressed in colon tumors and contain multiple epitopes that induce humoral and cellular immune responses in cancer patients
    Cancer Immunology, Immunotherapy, Vol. 57, No. 6. (June 2008), pp. 871-881.
  • Rapid accumulation of adoptively transferred CD8+ T cells at the tumor site is associated with long-term control of SV40 T antigen-induced tumors
    Cancer Immunology, Immunotherapy, Vol. 57, No. 6. (June 2008), pp. 883-895.
  • Autologous versus allogeneic peptide-pulsed dendritic cells for anti-tumour vaccination: expression of allogeneic MHC supports activation of antigen specific T cells, but impairs early naive cytotoxic priming and anti-tumour therapy
    Cancer Immunology, Immunotherapy, Vol. 57, No. 6. (June 2008), pp. 897-906.
  • Natural immunosurveillance against spontaneous, autochthonous breast cancers revealed and enhanced by blockade of IL-13-mediated negative regulation
    Cancer Immunology, Immunotherapy, Vol. 57, No. 6. (June 2008), pp. 907-912.
  • Dendritic cell vaccination and other strategies to tip the balance of the immune system: DC2007 5th international meeting, July 1618, Bamberg, Germany
    Cancer Immunology, Immunotherapy, Vol. 57, No. 6. (June 2008), pp. 913-928.
  • Dendritic cell vaccination and other strategies to tip the balance of the immune system: DC2007 5th international meeting, July 1618, Bamberg, Germany
    Cancer Immunology, Immunotherapy, Vol. 57, No. 6. (June 2008), pp. 929-930.
  • Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment
    Cancer Immunology, Immunotherapy, Vol. 56, No. 11. (November 2007), pp. 1687-1700.
  • T cells are crucial for the anti-metastatic effect of anti-epidermal growth factor receptor antibodies
    Cancer Immunology, Immunotherapy
    by Greta Garrido, Pablo Lorenzano, Belinda Sánchez, Irene Beausoleil, Daniel Alonso, Rolando Pérez, Luis Fernández
    posted by 1 person pjasper
  • Pattern of serum immunoreactivity against breast cancer cell lysates may predict severity of disease in breast cancer patients
    Cancer Immunology, Immunotherapy, Vol. 56, No. 11. (November 2007), pp. 1711-1721.
  • NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy
    Cancer Immunology, Immunotherapy, Vol. 56, No. 11. (November 2007), pp. 1723-1731.
  • Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice
    Cancer Immunology, Immunotherapy, Vol. 56, No. 11. (November 2007), pp. 1733-1742.
  • Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival
    Cancer Immunology, Immunotherapy, Vol. 56, No. 11. (November 2007), pp. 1743-1753.
  • ◇温馨提示◇本页的引用地址为: http://www.citeulike.org/journal/klu-262

    Result page: 1 2 3 4 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.